Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Jun 23 2021

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jun-23-2021-4

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 23, 2021, titled "Glenmark Pharmaceuticals receives ANDA approval for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit‐Dose Vials".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases